Literature DB >> 89105

The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.

D R Fischer, W Gevers, J N Klerk, S Kühn.   

Abstract

Acid phosphatase isozymes were investigated in cancerous prostatic tissue (4 cases) and benign prostatic hyperplasia (6 cases). Electron-microscopic histochemical examination of cancer tissue revealed irregular acid beta-glycerophosphatase staining in various cell organelles, including the plasma membrane, which was not seen in non-malignant tissue. Cancerous tissue homogenates also contained isozymic acid phosphatase species with high electrophoretic mobility, which was not detectable in benign tissue unless treated with detergent. Fractionation by differential centrifugation confirmed that much of the acid phosphatase activity in cancer tissue was extra-lysosomal. The detection of these isozyme properties may provide an opportunity, by means of tissue investigations, to define tumour stages earlier than on the basis of increased levels of serum acid phosphatase activity indicative of stage IV (D) prostatic cancer.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89105     DOI: 10.1007/BF02082231

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

1.  Estrogen inhibition of androgen-maintained prostatic secretion in the hypophysectomized dog.

Authors:  D A GOODWIN; D S RASMUSSEN-TAXDAL; A A FERREIRA; W W SCOTT
Journal:  J Urol       Date:  1961-07       Impact factor: 7.450

2.  A method for estimating serum acid phosphatase of prostatic origin.

Authors:  W H FISHMAN; F LERNER
Journal:  J Biol Chem       Date:  1953-01       Impact factor: 5.157

3.  The receptors of steroid hormones.

Authors:  B W O'Malley; W T Schrader
Journal:  Sci Am       Date:  1976-02       Impact factor: 2.142

4.  Soluble and membrane-associated forms of acid phosphatase associated with the lysosomal fraction of rat liver.

Authors:  B F Sloat; J M Allen
Journal:  Ann N Y Acad Sci       Date:  1969-10-14       Impact factor: 5.691

5.  Subunit structure of human prostatic acid phosphatase.

Authors:  E Luchter-Wasyl; W Ostrowski
Journal:  Biochim Biophys Acta       Date:  1974-10-09

6.  Fractionation and purification of prostatic acid phosphatase.

Authors:  V M Pais; A W Mangold; S A Mahoney
Journal:  Invest Urol       Date:  1974-07

7.  Adenomatoid tumors: a light microscopic, histochemical, and ultrastructural study.

Authors:  J B Taxy; H Battifora; R Oyasu
Journal:  Cancer       Date:  1974-08       Impact factor: 6.860

8.  Acid phosphatase content of prostatic exprimate from patients with advanced prostatic carcinoma: a potential prognostic and therapeutic index.

Authors:  J R Kent; M Hill; A Bischoff
Journal:  Cancer       Date:  1970-04       Impact factor: 6.860

9.  Biochemical properties of human prostatic acid phosphatase.

Authors:  K W Lam; O Li; C Y Li; L T Yam
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

10.  Cyto- and histomorphogenesis of the prostate carcinoma. A comparative light- and electron-microscopic study.

Authors:  H Kastendieck; E Altenähr
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.